ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Charlotte, NC, USA:

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherap...

Enrolling
Hodgkin Lymphoma
Drug: Etoposide
Drug: DTIC

Phase 2

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Charlotte, North Carolina, United States and 7 other locations

The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma...

Enrolling
Lymphoma
Solid Tumors
Drug: Chemotherapy
Drug: Eflapegrastim

Phase 2

Spectrum Pharmaceuticals
Spectrum Pharmaceuticals

Charlotte, North Carolina, United States and 3 other locations

dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...

Active, not recruiting
Mantle Cell Lymphoma
Relapsed Mantle Cell Lymphoma
Drug: BGB-11417

Phase 1, Phase 2

BeiGene
BeiGene

Charlotte, North Carolina, United States and 103 other locations

Locations recently updated

Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood cells). The purpose ...

Enrolling
Non-Hodgkin's Lymphoma
Drug: ABBV-291

Phase 1

AbbVie
AbbVie

Huntersville, North Carolina, United States of America and 3 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: vinblastine
Drug: brentuximab vedotin

Phase 3

Takeda
Takeda

Charlotte, North Carolina, United States and 215 other locations

with acute lymphoblastic leukemia (ALL) and acute lymphoblastic lymphoma (LLy).Primary Therapeutic Objectives:* To improve the event-free su...

Active, not recruiting
Acute Lymphoblastic Lymphoma
Acute Lymphoblastic Leukemia
Drug: Asparaginase Erwinia chrysanthemi (recombinant)-rywn
Drug: Thioguanine

Phase 2, Phase 3

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Charlotte, North Carolina, United States and 7 other locations

pharmacokinetic profile of GRC54276 alone and in combination with pembrolizumab or atezolizumab in participants with advanced solid tumors and lymphomas...

Active, not recruiting
Lymphoma
Advanced Solid Tumor
Drug: GRC 54276
Drug: GRC 54276 + Atezolizumab

Phase 1

Glenmark Pharmaceuticals

Huntersville, North Carolina, United States of America and 17 other locations

dose escalation and expansion clinical trial to evaluate the safety, tolerability and PK of HMPL-689 in patients with relapsed or refractory lymphomas...

Active, not recruiting
Lymphoma
Drug: HMPL-689

Phase 1

HUTCHMED
HUTCHMED

Charlotte, North Carolina, United States and 26 other locations

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...

Enrolling
Lymphoma, Non-Hodgkin
Drug: Fludarabine
Drug: JCAR017

Phase 2

Celgene
Celgene

Charlotte, North Carolina, United States and 56 other locations

The primary objective of Stage 1 is to evaluate the safety of nivolumab consolidation after completion of HD-MTX containing induction chemotherapy in...

Active, not recruiting
Eye and Orbit
Brain and Nervous System
Drug: Nivolumab

Phase 1

Wake Forest University (WFU)
Wake Forest University (WFU)

Charlotte, North Carolina, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems